CereVu is a company headquartered in the United States.
CereVu develops a wearable sensor-based platform that uses AI-derived biomarkers and near-infrared spectroscopy to provide objective, real-time measurement of pain and dyspnea for clinical research purposes.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.